Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature

<strong data-sider-select-id="8d61ce6e-75d0-45c1-b123-1a7d55ebe0ac">Background: Occult hepatitis B infection (OBI) refers to the presence of hepatitis B virus (HBV) DNA in the serum or liver of individuals who tested negative for HBV surface antigen (HBsAg). This study aimed to deter...

Full description

Saved in:
Bibliographic Details
Published inArchives of Iranian medicine Vol. 27; no. 6; pp. 305 - 312
Main Authors Hedayati-Moghaddam, Mohammad Reza, Tehranian, Farahnaz, Mosavat, Arman, Miri, Rahele, Ahmadi Ghezeldasht, Sanaz
Format Journal Article
LanguageEnglish
Published Iran Academy of Medical Sciences of I.R. Iran 01.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:<strong data-sider-select-id="8d61ce6e-75d0-45c1-b123-1a7d55ebe0ac">Background: Occult hepatitis B infection (OBI) refers to the presence of hepatitis B virus (HBV) DNA in the serum or liver of individuals who tested negative for HBV surface antigen (HBsAg). This study aimed to determine seropositivity for antibodies against HBV core antigen (anti-HBc) and the frequency of OBI among the HBsAg non-reactive blood donors in Mashhad, northeastern Iran. <strong data-sider-select-id="4ec3a440-0fd9-4f45-8cff-fb823071f58b">Methods: In this cross-sectional study, serum samples of HBsAg-negative blood donors were examined for anti-HBc during June and August 2018. Anti-HBc-positive samples were tested for antibodies against HBsAg (anti-HBs), and those with negative results were classified as isolated anti-HBc cases. The presence of HBV DNA in the C, S, and X gene regions was assessed by a qualitative real-time polymerase chain reaction method in all HBsAg-negative samples. OBI subjects were detected by the presence of at least one HBV genomic region. <strong data-sider-select-id="c931e660-3cf5-4914-984a-0ea3e497a58d">Results: Of 540 HBsAg-negative donors, 29 (5.4%; 95% confidence interval: 3.6–7.6%) showed seroreactivity for anti-HBc, of whom 18 individuals were also seropositive for anti-HBs. All donors showed negative results for all three HBV genes regardless of their serum anti-HBc status. <strong data-sider-select-id="0d3bd007-f43e-4e07-a126-b2064b1ef526">Conclusion: Based on our findings, we suggest routine screening of Iranian blood donation volunteers for serum anti-HBc and anti-HBs but not HBV DNA.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1029-2977
1735-3947
DOI:10.34172/aim.28579